LON:BMK Benchmark Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Benchmark Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 46.66 -0.84 (-1.76%) (As of 07/1/2022 02:35 PM ET) Add Compare Share Today's Range 46.67▼ 46.6750-Day Range 40▼ 5452-Week Range 39▼ 65.90Volume31 shsAverage Volume566,557 shsMarket Capitalization£328.50 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlines Benchmark Stock Forecast (MarketRank)Analyst RatingN/AUpside/DownsideN/AShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares£2.92 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.0.39 out of 5 stars 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Benchmark. Previous Next 0.0 Short Interest Short InterestThere is no current short interest data available for BMK. Previous Next 0.0 Dividend Strength Dividend YieldBenchmark does not currently pay a dividend.Dividend GrowthBenchmark does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for BMK. Previous Next 1.1 News and Social Media Coverage News SentimentBenchmark has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Medical companies. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Benchmark insiders have bought more of their company's stock than they have sold. Specifically, they have bought £29,166.36 in company stock and sold GBX 0 in company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Benchmark is -17.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Benchmark is -17.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDue to a projected decrease in earnings for Benchmark, their PEG ratio cannot be calculated.Price to Book Value per Share RatioBenchmark has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive BMK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Benchmark and its competitors with MarketBeat's FREE daily newsletter. Email Address About Benchmark (LON:BMK)Benchmark Holdings plc, together with its subsidiaries, provides technical services, products, and specialist knowledge that supports the development of food and farming industries in the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, rest of the Europe, and internationally. The company operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers salmon breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products to the aquaculture market. Benchmark Holdings plc was founded in 2000 and is based in Sheffield, the United Kingdom.Read More BMK Stock News HeadlinesJune 1, 2022 | ca.proactiveinvestors.comBenchmark Holdings converts Norway debt to green loan after meeting ESG criteriaMay 18, 2022 | proactiveinvestors.com.auBenchmark Holdings shares boosted by 'excellent' first halfMay 18, 2022 | ca.proactiveinvestors.comBenchmark Holdings shares boosted by “excellent” first halfApril 30, 2022 | finanznachrichten.deLandesbank Baden-Württemberg - Pre-stabilisation Period AnnouncementMarch 3, 2022 | finance.yahoo.comQuite a few insiders invested in Benchmark Holdings plc (LON:BMK) last year which is positive news for shareholdersFebruary 26, 2022 | uk.finance.yahoo.comBenchmark Holdings plc (BMK.L)December 3, 2021 | finance.yahoo.comBenchmark Holdings plc (LON:BMK) Just Released Its Yearly Earnings: Here's What Analysts ThinkDecember 1, 2021 | markets.businessinsider.comBenchmark Hlgs PLC : PCA DealingNovember 30, 2021 | markets.businessinsider.comBenchmark Hlgs PLC : Q4 ResultsNovember 24, 2021 | au.finance.yahoo.comThe Best Samsung Galaxy Tablet Black Friday Deals (2021): Top Galaxy Tab A7, S7 & More Tablet Deals Monitored by The Consumer PostSeptember 1, 2021 | finance.yahoo.comAnalysts Expect Breakeven For Benchmark Holdings plc (LON:BMK) Before LongAugust 20, 2021 | barrons.comBenchmark Holdings PLCAugust 17, 2021 | benzinga.comAquaManager Partners With Leading Tilapia Genetics Company Spring GeneticsSee More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolLON:BMK CUSIPN/A CIKN/A Webwww.benchmarkplc.com Phone+44-114-2409935FaxN/AEmployees796Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio34.57 P/E Growth-34.89Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio42.29 Current Ratio2.54 Quick Ratio1.70 Sales & Book Value Annual Sales£144.84 million Price / Sales2.27 Cash FlowGBX 6.35 per share Price / Cash Flow7.35 Book ValueGBX 41.70 per share Price / Book1.12Miscellaneous Outstanding Shares703,961,000Free FloatN/AMarket Cap£328.50 million OptionableNot Optionable BetaN/A Benchmark Frequently Asked Questions How has Benchmark's stock performed in 2022? Benchmark's stock was trading at GBX 57 at the beginning of the year. Since then, BMK shares have decreased by 18.1% and is now trading at GBX 46.67. View the best growth stocks for 2022 here. Who are Benchmark's key executives? Benchmark's management team includes the following people: Mr. Trond Williksen, CEO & Director (Age 59, Pay $817.52k)Ms. Septima Maguire, CFO & DirectorMs. Ruth Layton, Co-Founder & Head of Benchmark Sustainability ScienceMr. Neil Robertson, Head of OperationsMs. Ivonne Maria Gloria Cantu, Director of Investor Relations & Corp. Devel. (Age 53)Ms. Jennifer Haddouk, Company Sec. & Group Legal CounselMs. Corina Holmes, Group Head of PeopleMr. Roland James Bonney, Group Lead of Key Account Management (Age 58)Mr. David Babington, Managing Director of Improve InternationalMr. John Marshall, Head of Animal Health Who are some of Benchmark's key competitors? Some companies that are related to Benchmark include Hydropothecary (THCX), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Amryt Pharma (AMYT), HLS Therapeutics (HLS), OrganiGram (OGI), Supreme Cannabis (FIRE), ESSA Pharma (EPI), ICC Labs (ICC), Leaf Mobile (LEAF), Medexus Pharmaceuticals (MDP), HEXO (HEXO), BioSyent (RX), Green Organic Dutchman (TGOD) and Delta 9 Cannabis (NINE). View all of BMK's competitors. What other stocks do shareholders of Benchmark own? Based on aggregate information from My MarketBeat watchlists, some companies that other Benchmark investors own include Indivior (INDV), Allena Pharmaceuticals (ALNA), (RED), Ampliphi Biosciences (APHB), Clinigen Group (CLIN), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), American Campus Communities (ACC), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX). What is Benchmark's stock symbol? Benchmark trades on the London Stock Exchange (LON) under the ticker symbol "BMK." How do I buy shares of Benchmark? Shares of BMK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Benchmark's stock price today? One share of BMK stock can currently be purchased for approximately GBX 46.67. How much money does Benchmark make? Benchmark (LON:BMK) has a market capitalization of £328.50 million and generates £144.84 million in revenue each year. How many employees does Benchmark have? Benchmark employs 796 workers across the globe. How can I contact Benchmark? Benchmark's mailing address is Benchmark House, 8 Smithy Wood Drive, SHEFFIELD, S35 1QN, United Kingdom. The official website for Benchmark is www.benchmarkplc.com. The company can be reached via phone at +44-114-2409935. This page (LON:BMK) was last updated on 7/1/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here